"Le Centre Hospitalier de Bligny est un établissement privé à but non-lucratif, spécialisé en réadaptation cardiaque, réhabilitation respiratoire, hématologie, oncologie, diabétologie et maladies infectieuses. Il comporte un secteur de COURT SÉJOUR de médecine, ainsi qu'un secteur de SOINS DE SUITE ET RÉADAPTATION. Prenez contact."

During the past decade, CMC Bligny conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CMC Bligny" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "French Cardiology Society" with 2 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CMC Bligny" #1 collaborator was "Adep Assistance" with 1 trials as a collaborator, "Arbeitsgruppe Lebermetastasen und Tumoren" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Fondation Francaise de Cancerologie Digestive" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "CMC Bligny" are "Colorectal Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Anxiety" (1 trials), "Breast Cancer" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "CMC Bligny" in a lesser frequency.

Most popular intervention types in "CMC Bligny" are "Drug" (7 trials), "Other" (4 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "fluorouracil" (3 trials), "leucovorin calcium" (3 trials), "conventional surgery" (2 trials), "gemcitabine hydrochloride" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "CMC Bligny" are 13 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CMC Bligny". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CMC Bligny, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMC Bligny, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".